1	Characterization	characterization	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	nuclear	nuclear	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	cytoplasmic	cytoplasmic	_	_	_	_	_	_	_
7	components	component	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	lymphoid-specific	lymphoid-specific	_	_	_	_	_	_	_
11	nuclear	nuclear	_	_	_	_	_	_	_
12	factor	factor	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	activated	activate	_	_	_	_	_	_	_
15	T	t	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	NF-AT	NF-AT	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	complex	complex	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	lymphoid-specific	lymphoid-specific	_	_	_	_	_	_	_
3	transcription	transcription	_	_	_	_	_	_	_
4	complex	complex	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	NF-AT	NF-AT	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	involved	involve	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	early	early	_	_	_	_	_	_	_
12	gene	gene	_	_	_	_	_	_	_
13	activation	activation	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	T	t	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	is	be	_	_	_	_	_	_	_
19	assembled	assemble	_	_	_	_	_	_	_
20	from	from	_	_	_	_	_	_	_
21	a	a	_	_	_	_	_	_	_
22	pre-existing	pre-existing	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	T	t	_	_	_	_	_	_	_
25	cell	cell	_	_	_	_	_	_	_
26	restricted	restricted	_	_	_	_	_	_	_
27	cytoplasmic	cytoplasmic	_	_	_	_	_	_	_
28	factor	factor	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	an	an	_	_	_	_	_	_	_
31	inducible	inducible	_	_	_	_	_	_	_
32	ubiquitous	ubiquitous	_	_	_	_	_	_	_
33	nuclear	nuclear	_	_	_	_	_	_	_
34	component	component	_	_	_	_	_	_	_
35	within	within	_	_	_	_	_	_	_
36	30	30	_	_	_	_	_	_	_
37	min	min	_	_	_	_	_	_	_
38	after	after	_	_	_	_	_	_	_
39	activation	activation	_	_	_	_	_	_	_
40	through	through	_	_	_	_	_	_	_
41	the	the	_	_	_	_	_	_	_
42	antigen	antigen	_	_	_	_	_	_	_
43	receptor	receptor	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	Recent	recent	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	have	have	_	_	_	_	_	_	_
4	implicated	implicate	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	family	family	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	AP1	ap1	_	_	_	_	_	_	_
9	factors	factor	_	_	_	_	_	_	_
10	as	as	_	_	_	_	_	_	_
11	components	component	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	murine	murine	_	_	_	_	_	_	_
15	NF-AT	nf-at	_	_	_	_	_	_	_
16	complex	complex	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Evidence	evidence	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	provided	provide	_	_	_	_	_	_	_
4	here	here	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	nuclear	nuclear	_	_	_	_	_	_	_
8	component	component	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	human	human	_	_	_	_	_	_	_
11	NF-AT	nf-at	_	_	_	_	_	_	_
12	contains	contain	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	phorbol	phorbol	_	_	_	_	_	_	_
15	ester-inducible	ester-inducible	_	_	_	_	_	_	_
16	transcription	transcription	_	_	_	_	_	_	_
17	factor	factor	_	_	_	_	_	_	_
18	AP1	AP1	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	Jun/Fos	Jun/Fos	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	further	further	_	_	_	_	_	_	_
3	characterize	characterize	_	_	_	_	_	_	_
4	which	which	_	_	_	_	_	_	_
5	AP1	ap1	_	_	_	_	_	_	_
6	family	family	_	_	_	_	_	_	_
7	members	member	_	_	_	_	_	_	_
8	can	can	_	_	_	_	_	_	_
9	assume	assume	_	_	_	_	_	_	_
10	this	this	_	_	_	_	_	_	_
11	role	role	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Antisera	Antiserum	_	_	_	_	_	_	_
2	to	to	_	_	_	_	_	_	_
3	Fos	Fos	_	_	_	_	_	_	_
4	inhibits	inhibit	_	_	_	_	_	_	_
5	NF-AT	NF-AT	_	_	_	_	_	_	_
6	DNA	DNA	_	_	_	_	_	_	_
7	binding	binding	_	_	_	_	_	_	_
8	as	as	_	_	_	_	_	_	_
9	does	do	_	_	_	_	_	_	_
10	an	an	_	_	_	_	_	_	_
11	oligonucleotide	oligonucleotide	_	_	_	_	_	_	_
12	containing	contain	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	binding	bind	_	_	_	_	_	_	_
15	site	site	_	_	_	_	_	_	_
16	for	for	_	_	_	_	_	_	_
17	AP1	AP1	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Constitutive	constitutive	_	_	_	_	_	_	_
2	expression	expression	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	vivo	vivo	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	Fos	Fos	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	lesser	less	_	_	_	_	_	_	_
12	extent	extent	_	_	_	_	_	_	_
13	Fra-1	fra-1	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	eliminates	eliminate	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	requirement	requirement	_	_	_	_	_	_	_
18	for	for	_	_	_	_	_	_	_
19	phorbol	phorbol	_	_	_	_	_	_	_
20	12-myristate	12-myristate	_	_	_	_	_	_	_
21	13-acetate	13-acetate	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	PMA	PMA	_	_	_	_	_	_	_
24	)	)	_	_	_	_	_	_	_
25	stimulation	stimulation	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	leaving	leave	_	_	_	_	_	_	_
28	NF-AT-directed	nf-at-directed	_	_	_	_	_	_	_
29	transcription	transcription	_	_	_	_	_	_	_
30	responsive	responsive	_	_	_	_	_	_	_
31	to	to	_	_	_	_	_	_	_
32	calcium	calcium	_	_	_	_	_	_	_
33	ionophore	ionophore	_	_	_	_	_	_	_
34	alone	alone	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	Overexpression	overexpression	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	cJun	cjun	_	_	_	_	_	_	_
4	or	or	_	_	_	_	_	_	_
5	JunD	JunD	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	but	but	_	_	_	_	_	_	_
8	not	not	_	_	_	_	_	_	_
9	JunB	JunB	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	also	also	_	_	_	_	_	_	_
12	eliminates	eliminate	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	requirement	requirement	_	_	_	_	_	_	_
15	for	for	_	_	_	_	_	_	_
16	PMA	PMA	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	indicating	indicate	_	_	_	_	_	_	_
19	that	that	_	_	_	_	_	_	_
20	many	many	_	_	_	_	_	_	_
21	but	but	_	_	_	_	_	_	_
22	not	not	_	_	_	_	_	_	_
23	all	all	_	_	_	_	_	_	_
24	Jun-	jun-	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	Fos-related	fos-related	_	_	_	_	_	_	_
27	proteins	protein	_	_	_	_	_	_	_
28	functionally	functionally	_	_	_	_	_	_	_
29	activate	activate	_	_	_	_	_	_	_
30	NF-AT-dependent	nf-at-dependent	_	_	_	_	_	_	_
31	transcription	transcription	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	presence	presence	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	the	the	_	_	_	_	_	_	_
37	cytoplasmic	cytoplasmic	_	_	_	_	_	_	_
38	component	component	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	NF-AT	NF-AT	_	_	_	_	_	_	_
2	DNA	DNA	_	_	_	_	_	_	_
3	binding	binding	_	_	_	_	_	_	_
4	can	can	_	_	_	_	_	_	_
5	be	be	_	_	_	_	_	_	_
6	reconstituted	reconstitute	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	vitro	vitro	_	_	_	_	_	_	_
9	using	use	_	_	_	_	_	_	_
10	semi-purified	semi-purified	_	_	_	_	_	_	_
11	AP1	ap1	_	_	_	_	_	_	_
12	proteins	protein	_	_	_	_	_	_	_
13	mixed	mix	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	cytosol	cytosol	_	_	_	_	_	_	_
16	from	from	_	_	_	_	_	_	_
17	T	t	_	_	_	_	_	_	_
18	lymphocytes	lymphocyte	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Fos	Fos	_	_	_	_	_	_	_
2	proteins	protein	_	_	_	_	_	_	_
3	are	be	_	_	_	_	_	_	_
4	not	not	_	_	_	_	_	_	_
5	needed	need	_	_	_	_	_	_	_
6	for	for	_	_	_	_	_	_	_
7	this	this	_	_	_	_	_	_	_
8	reconstitution	reconstitution	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	although	although	_	_	_	_	_	_	_
12	JunB	JunB	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	not	not	_	_	_	_	_	_	_
15	functional	functional	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	it	it	_	_	_	_	_	_	_
18	can	can	_	_	_	_	_	_	_
19	participate	participate	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	NF-AT	NF-AT	_	_	_	_	_	_	_
23	DNA	DNA	_	_	_	_	_	_	_
24	binding	binding	_	_	_	_	_	_	_
25	complex	complex	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Finally	finally	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	we	we	_	_	_	_	_	_	_
4	have	have	_	_	_	_	_	_	_
5	partially	partially	_	_	_	_	_	_	_
6	purified	purify	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	cytoplasmic	cytoplasmic	_	_	_	_	_	_	_
9	component	component	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	NF-AT	NF-AT	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	show	show	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	elution	elution	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	renaturation	renaturation	_	_	_	_	_	_	_
18	from	from	_	_	_	_	_	_	_
19	SDS-polyacrylamide	SDS-polyacrylamide	_	_	_	_	_	_	_
20	gel	gel	_	_	_	_	_	_	_
21	electrophoresis	electrophoresis	_	_	_	_	_	_	_
22	gels	gel	_	_	_	_	_	_	_
23	that	that	_	_	_	_	_	_	_
24	it	it	_	_	_	_	_	_	_
25	has	have	_	_	_	_	_	_	_
26	a	a	_	_	_	_	_	_	_
27	molecular	molecular	_	_	_	_	_	_	_
28	mass	mass	_	_	_	_	_	_	_
29	between	between	_	_	_	_	_	_	_
30	94	94	_	_	_	_	_	_	_
31	and	and	_	_	_	_	_	_	_
32	116	116	_	_	_	_	_	_	_
33	kDa	kda	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	may	may	_	_	_	_	_	_	_
36	have	have	_	_	_	_	_	_	_
37	multiple	multiple	_	_	_	_	_	_	_
38	differentially	differentially	_	_	_	_	_	_	_
39	modified	modified	_	_	_	_	_	_	_
40	forms	form	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

